Elravie Premier Light-L — HI Technology HA Filler for Fine Wrinkles (1ml)

Elravie Premier Light-L is Humedix’s superficial-grade monophasic HA filler — 23 mg/mL cross-linked hyaluronic acid + 0.3% lidocaine using patented HI (High molecular Ideal Reticulated Matrix) Technology. HA purity above 99.5%, endotoxin under 0.05 EU/mL. Engineered for superficial dermal placement targeting fine perioral lines, crow’s feet, and forehead wrinkles. 9-12 month durability.

Elravie Premier Light-L Filler is manufactured by Humedix Co. Ltd., a South Korea-based medical device and pharmaceutical company established in 2003. The product is part of the Elravie Premier dermal filler range, which is distributed across multiple international markets. Regulatory status: KFDA registered · CE marked · GMP certified · ISO.

Elravie Premier Light-L Filler contains 23 mg/mL of cross-linked hyaluronic acid plus 0.3% (3 mg/mL) premixed lidocaine for injection comfort. The hyaluronic acid is non-animal, produced by bacterial fermentation and cross-linked using Humedix Co. Ltd.’s HI (High molecular Ideal Reticulated Matrix) Technology technology. Phosphate-buffered saline at near-physiological pH carries the gel.

Per Humedix Co. Ltd.’s clinical data, Elravie Premier Light-L Filler delivers 9-12 months of correction depending on placement and patient factors. Duration depends on injection depth, dose, anatomical site, patient metabolism, and facial movement intensity. Superficial dermis placement typically delivers the longer end of the duration range.

Elravie Premier Light-L Filler is engineered for superficial dermis placement. The standard recommended needle is 30G, supplied in the syringe blister pack. Some practitioners prefer a blunt-tip cannula of equivalent gauge for safer placement in highly vascular zones, particularly for deeper subcutaneous work.

Elravie Premier Light-L Filler regulatory status: KFDA registered · CE marked · GMP certified · ISO. The product’s KFDA registration in South Korea is the primary regulatory baseline. CE marking and other international approvals enable distribution in the EU and other regulated markets. US FDA status varies — buyers in regulated jurisdictions should verify approval scope before importation and clinical use.

Store Elravie Premier Light-L Filler between 2 °C and 25 °C in original packaging, away from direct sunlight. Do not freeze — freezing damages the HA gel structure. Shelf life is typically 24 months from the manufacturing date printed on the box when unopened. Once a syringe is opened, contents must be used immediately. Partial syringes cannot be retained for later use due to sterility risk.

No. Elravie Premier Light-L Filler uses non-animal hyaluronic acid produced by bacterial fermentation — the standard manufacturing approach for modern HA dermal fillers. The product contains no animal proteins or by-products, making it suitable for patients who avoid animal-derived medical products. The product is contraindicated in patients with severe allergies to gram-positive bacterial proteins (used in HA fermentation).

Yes — layered protocols combining different fillers are standard aesthetic practice. Elravie Premier Light-L Filler can be combined with other Korean or international HA fillers, neuromodulators (botulinum toxin), or biostimulators (PLLA, calcium hydroxylapatite) within a single session. Always wait the recommended interval between different injectable products and confirm biocompatibility per each manufacturer’s IFU.

HI (High molecular Ideal Reticulated Matrix) Technology is Humedix’s proprietary cross-linking process that activates hyaluronic acid molecules to form the maximum number of HA-BDDE bonds during cross-linking. The result: a stable, dense reticulated gel matrix with significantly reduced residual BDDE — minimising the risk of post-injection swelling and allergic reactions. Combined with TFF UF (Tangential Flow Filtration Ultra Filtration) purification and the NIA (Non-Inflammation Asepsis) method, Elravie Premier achieves HA purity above 99.5% and endotoxin levels under 0.05 EU/mL.